The Egyptian Drug Authority (EDA) announced the conclusion of a training program focused on the regulation of medical product advertising, import procedures, and customs clearance. The program was delivered to the South African Health Products Regulatory Authority (SAHPRA) via video conference, as part of fostering cooperation between pharmaceutical regulatory authorities in Africa in accordance with World Health Organization (WHO) requirements.

The program aimed to enhance the regulatory capacities of SAHPRA, contributing to the transfer of expertise and the development of regulatory systems according to international standards. This reflects the EDA's continuous commitment to developing the pharmaceutical regulatory framework and strengthening cooperation with counterpart authorities to support the quality, safety, and efficacy of medical products globally.

During the sessions, Dr. Moaz Masoud, General Manager of the General Administration for Marketing and Advertising Materials Regulation, reviewed WHO indicators regarding advertising regulations. He highlighted the pioneering Egyptian experience, mechanisms for governing promotional materials, and tools for preparing supporting evidence such as Standard Operating Procedures (SOPs), application checklists, review mechanisms, and relevant regulatory decrees. Additionally, Dr. Nourhan Tahoun, Manager of the Import and Customs Clearance Department, presented a briefing on WHO indicators and requirements related to the import and distribution of medical products and raw materials used in manufacturing, as well as customs clearance mechanisms that ensure the safety and quality of inputs.

The program witnessed extensive interaction from participants, involving discussions on the practical application of international indicators and ways to align national requirements with WHO standards, while praising the Egyptian model in pharmaceutical market oversight.

This initiative reflects the commitment of the Egyptian Drug Authority, led by Dr. Ali El-Ghamrawy, Chairman of the Egyptian Drug Authority, to provide technical support and consultancy to sister pharmaceutical authorities in Africa. It underscores its dedication to unifying regulatory standards across the continent to ensure access to safe and effective medicine for all African peoples, solidifying Egypt’s position as a regional hub for pharmaceutical regulation and legislation.